Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative (IMSLNB-EBCP)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2013 by Shandong Cancer Hospital and Institute.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Yongsheng Wang, Shandong Cancer Hospital and Institute
ClinicalTrials.gov Identifier:
NCT01642511
First received: July 11, 2012
Last updated: August 24, 2013
Last verified: August 2013